References
- AkesbiJBrousseaudFXAdamRRodallecTNordmannJPIntravitreal bevacizumab (Avastin) in idiopathic retinitis, vasculitis, aneurysms and neuroretinitisActa Ophthalmol20108824041
- Ben YahiaSHerbortCPJenzeriSIntravitreal bevacizumab (Avastin) as primary and rescue treatment for choroidal neovascularization secondary to ocular toxoplasmosisInt Ophthalmol200828431131618401552
- ChanWMLaiTYLiuDTLamDSIntravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic originAm J Ophthalmol2007143697798317459318
- GuthoffRGoebelWIntravitreal bevacizumab for choroidal neovascularization in toxoplasmosisActa Ophthalmol200987668869018631326
- JulianKTerradaCFardeauCIntravitreal bevacizumab as first local treatment for uveitis-related choroidal neovascularization: long-term resultsActa Ophthalmol201189217918421348964
- KucukerdonmezCAkovaYAYilmazGIntravitreal injection of bevacizumab in Eales diseaseOcul Immunol Inflamm2008161636518379947
- KurupSLewJByrnesGYehSNussenblattRLevy-ClarkeGTherapeutic efficacy of intravitreal bevacizumab on posterior uveitis complicated by neovascularizationActa Ophthalmol200987334935218513266
- RaffaLBawazeerAIntravitreal bevacizumab injection in a 14-year-old Vogt–Koyanagi–Harada patient with choroidal neovascular membraneCan J Ophthalmol200944561561619789612
- TranTHFardeauCTerradaCIntravitreal bevacizumab for refractory choroidal neovascularization (CNV) secondary to uveitisGraefes Arch Clin Exp Ophthalmol2008246121685169218682970
- MansourAMArevaloJFFardeauCThree-year visual and anatomic results of administrating intravitreal bevacizumab in inflammatory ocular neovascularizationCan J Ophthalmol201247326927422687305
- MansourAMArevaloJFZiemssenFLong-term visual outcomes of intravitreal bevacizumab in inflammatory ocular neovascularizationAm J Ophthalmol2009148231031619427992
- MansourAMMackensenFArevaloJFIntravitreal bevacizumab in inflammatory ocular neovascularizationAm J Ophthalmol2008146341041618619571
- AdanAMateoCNavarroRIntravitreal bevacizumab (avastin) injection as primary treatment of inflammatory choroidal neovascularizationRetina20072791180118618046222
- BeneventoJDJagerRDNobleAGToxoplasmosis-associated neovascular lesions treated successfully with ranibizumab and antiparasitic therapyArch Ophthalmol200812681152115618695115
- DoctorPPBhatPSayedRFosterCSIntravitreal bevacizumab for uveitic choroidal neovascularizationOcul Immunol Inflamm200917211812619412874
- EhrlichRCiullaTAMaturiRIntravitreal bevacizumab for choroidal neovascularization secondary to presumed ocular histoplasmosis syndromeRetina200929101418142319898179
- FineHFZhitomirskyIFreundKBBevacizumab (avastin) and ranibizumab (lucentis) for choroidal neovascularization in multifocal choroiditisRetina200929181218784620
- KramerMAxer-SiegelRJaouniTBevacizumab for choroidal neovascularization related to inflammatory diseasesRetina201030693894420168273
- KumarASinhaSRapid regression of disc and retinal neovascularization in a case of Eales disease after intravitreal bevacizumabCan J Ophthalmol200742233533617392871
- LottMNSchiffmanJCDavisJLBevacizumab in inflammatory eye diseaseAm J Ophthalmol2009148571171719660732
- MenezoVCuthbertsonFDownesSMPositive response to intravitreal ranibizumab in the treatment of choroidal neovascularization secondary to punctate inner choroidopathyRetina20103091400140420224465
- RouvasAPetrouPDouvaliMIntravitreal ranibizumab for the treatment of inflammatory choroidal neovascularizationRetina201131587187921358461
- SchadluRBlinderKJShahGKIntravitreal bevacizumab for choroidal neovascularization in ocular histoplasmosisAm J Ophthalmol2008145587587818321466
- VossmerbaeumerUSpandauUHBaltzSWickenhaeuserAJonasJBIntravitreal bevacizumab for choroidal neovascularization secondary to punctate inner choroidopathyClin Experiment Ophthalmol200836329229418412603
- KleinerRCRatnerCMEngerCFineSLSubfoveal neovascularization in the ocular histoplasmosis syndrome. A natural history studyRetina1988842252292466316
- BrownJJrFolkJCReddyCVKimuraAEVisual prognosis of multifocal choroiditis, punctate inner choroidopathy, and the diffuse subretinal fibrosis syndromeOphthalmology19961037110011058684800
- PerentesYChanCCBoveyEUfferSHerbortCPMassive vascular endothelium growth factor (VEGF) expression in Eales’ diseaseKlin Monbl Augenheilkd2002219431131412022026
- GuerinESheridanCAsshetonDSDF1-alpha is associated with VEGFR-2 in human choroidal neovascularisationMicrovasc Res200875330230718234239
- MaruottiNCantatoreFPNicoBVaccaARibattiDAngiogenesis in vasculitidesClin Exp Rheumatol200826347648318578974
- MurugeswariPShuklaDRajendranAKimRNamperumalsamyPMuthukkaruppanVProinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and Eales’ diseaseRetina200828681782418536597
- ShimadaHYuzawaMHiroseTNakashizukaHHattoriTKazatoYPathological findings of multifocal choroiditis with panuveitis and punctate inner choroidopathyJpn J Ophthalmol200852428228818773266
- GulatiNForooghianFLiebermanRJabsDAVascular endothelial growth factor inhibition in uveitis: a systematic reviewBr J Ophthalmol201195216216520494915
- KaiserPKProspective evaluation of visual acuity assessment: a comparison of Snellen versus ETDRS charts in clinical practice (an AOS thesis)Trans Am Ophthalmol Soc200910731132420126505